FDA approves first treatment for chronic rhinosinusitis with nasal polyps - FDA Press Releases

FDA approves Dupixent to treat adults with nasal polyps accompanied by chronic rhinosinusitis or prolonged inflammation of the sinuses and nasal cavity.

from FDA Press Releases RSS Feed https://ift.tt/2Ylphb6
via IFTTT